Marina Udier
Direttore/Membro del Consiglio presso CELYAD ONCOLOGY SA
Posizioni attive di Marina Udier
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Direttore/Membro del Consiglio | 11/01/2011 | - |
| Independent Dir/Board Member | 11/01/2011 | - | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Direttore/Membro del Consiglio | 01/01/2016 | - |
| Amministratore Delegato | 01/05/2019 | - | |
| Direttore operativo | 01/01/2016 | 26/02/2020 | |
| Nouscom Srl | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - |
Storia della carriera di Marina Udier
Precedenti posizioni note di Marina Udier
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Direttore operativo | 01/01/2016 | - |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
Formazione di Marina Udier
| Yale University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 3 |
| Stati Uniti | 3 |
| Belgio | 2 |
Posizioni
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| NOVARTIS AG | Health Technology |
| Aziende private | 3 |
|---|---|
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Health Technology |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
| Nouscom Srl | Commercial Services |
- Borsa valori
- Insiders
- Marina Udier
- Esperienza
